Markenzie Jean-baptiste
Psych Drug Cards
4/9/2020
| Drug Name: Quetiapine (Seroquel) |
| Drug class: 2nd gen Anti-Psychotic
MOA: antagonizes Dopamine D2 receptors and Serotonin 5-HT2 Receptors, exact MOA unknown Indications: Schizophrenia, Bipolar Disorder, Generalized Anxiety Contraindications: hypersensitivities, electrolyte abnormality, QT prolongation Adverse rxn: suicidality, extrapyramidal sx’s( lower incidence), Neuroleptic Malignant Syndrome, QT prolongation, Leukopenia Monitor: suicidality, lipid panel, fasting glucose, CBC w/ diff Dose: 150-750 mg /day divided BID-TID, Max 800 mg /day |
| Drug Name: Haloperidol |
| Drug class: 1st gen Antipsychotic
MOA: Selectively antagonized Dopamine D2 receptors , exact MOA unknown Indications: Psychosis, Agitation, Tourette Syndrome Contraindications: hypersensitivities to drug, Parkinson Disease, coma, CNS depression Adverse rxn: extrapyramidal sx’s, QT prolongation, Neuroleptic Malignant Syndrome, hyperpyrexia, leukopenia Monitor: CBC w /diff Dose: 0.5-5 mg PO BID-TID, Max 100 mg /day for severe refractory cases |
| Drug Name: Risperidone |
| Drug class: 2nd gen Anti-Psychotic
MOA: antagonizes Dopamine D2 receptors and Serotonin 5-HT2 Receptors, exact MOA unknown Indications: Schizophrenia, Bipolar Disorder, Tourette Syndrome Contraindications: hypersensitivities to drug or to Paliperidone Adverse rxn: syncope, extrapyramidal sx’s, Neuroleptic Malignant Syndrome, diabetes, Leukopenia Monitor: creatinine at baseline, fasting glucose, CBC Dose: 1-3mg /day PO divided QD-BID Max 16 mg/day |
| Drug Name: Lorazepam (Ativan) |
| Drug class: Benzodiazepine
MOA: binds to benzodiazepine receptors, enhances GABA inhibitory effects Indications: anxiety, alcohol withdrawal, status epilepticus, delirium tremens, Contraindications: intra-arterial administration, respiratory impairment, neonates/infants Adverse rxn: respiratory depression, seizure, syncope, suicidality, gangrene (intra-arterial inj) Monitor: LFT’s, Respiratory function/Black box warning: respiratory depression, coma, death when given w/ opioids Dose: 2-6 mg/day PO/IM/IV divided bid-tid, Max 10 mg /day |
| Drug Name: Escitalopram(Lexapro) |
| Drug class: selective serotonin reuptake inhibitor (SSRI)
MOA: selectively inhibits serotonin reuptake Indications: Depression, Anxiety Contraindications: hypersensitivities, use during or within 14 days of MAOI (can cause serotonin syndrome) Adverse rxn: suicidality, depression exacerbation, hypomania/mania, QT prolongation, serotonin syndrome Monitor: suicidality, ECG for qt prolongation Dose: 10 mg PO QD, may increase after 1 week, Max 20 mg /day |
Source: Epocrates
This entry is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license.
